Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Stroke Issues Author: Staff Editor Last Updated: Jan 6, 2014 - 1:56:52 PM



Enzyme Mutations May Protect Against Stroke

By Staff Editor
Jan 6, 2014 - 1:53:53 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - New Haven, Conn.- Yale researchers have identified the mechanism behind a molecular variation that reduces risk of stroke in children with sickle cell anemia. The molecular variation was recently identified but not understood due to a limited grasp of the gene's role in hemostasis - the stopping of bleeding. These new findings open a path for the development of novel drugs that may prevent stroke, particularly in children with sickle cell anemia who are at risk of this devastating complication. The study appears online in the Journal of Biological Chemistry.

The researchers demonstrate that an enzyme known as NPP1, encoded by the gene associated with stroke protection, is part of a family of enzymes that encourages the coagulation of blood on vascular surfaces. Too much clotting on the vascular lining can lead to thrombosis and stroke. By demonstrating that NPP1 can induce platelet aggregation at low concentrations (on the vascular lining, for example), the team established a direct role for the enzyme in thrombotic stroke.

"Our findings strongly suggest that NPP1 inhibitors would confer some level of stroke protection to patients at risk for thrombotic stroke, especially to children with sickle cell anemia in whom the NPP1 variation was identified," said senior author Demetrios Braddock, M.D., associate professor of pathology at Yale School of Medicine.

The team also determined the molecular structure of a close relative of NPP1 called NPP4, which revealed the molecular details of the target site for new inhibitors directed against the gene - further enabling the possible design of novel anti-stroke drugs.

Other authors are Ronald Albright, Wenxiang Cao, William Chang, Martin Tehan, Denton Hoyer, Lynn Liu, Paul Stabach, Guangxiao Yang, and Enrique De La Cruz of Yale; Deborah Ornstein and Donna Robert of the Geisel School of Medicine at Dartmouth.

The study was supported by a grant from the Connecticut Department of Public Health.

DOI: 10.1074/jbc.M113.505867


###

For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.

 



Top of Page

HealthNewsDigest.com

Stroke Issues
Latest Headlines


+ ER Doctors Commonly Miss More Strokes Among Women, Minorities and Younger Patients
+ UT Southwestern Certified as Advanced Comprehensive Stroke Center
+ Treat a Mini-stroke as Seriously as a Big One
+ Artery-clearing Surgery After Stroke Should be Delayed
+ Heart Attacks, Stroke at Work Often Follow Vigorous Physical Activity
+ Treating Stroke Patients with Intravenous Magnesium within an Hour of Symptom Onset Fails to Improve Stroke Outcome
+ Weather Changes May be Linked to Stroke Hospitalizations
+ Stroke Trigger More Deadly for African-Americans
+ Calcium Measurement and Prediction of Heart Attack or Stroke
+ Daily Low-dose Aspirin Can Prevent Heart Attack and Stroke but is Often Misused



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions